Currently Viewing:
AcademyHealth 2018 National Health Policy Conference
Health Reform X.0 Panel Debates Medicaid, Other Topics at Health Policy Conference
February 05, 2018
Policy Talk Tries Shifting Conversation About Who Pays for What in Healthcare
February 06, 2018
As Budget Deadline Looms, Former Congressional Aides Talk Health Policy at Conference
February 06, 2018
Surgeon General to Policy Conference: Let's Link Health to Economy, Defense
February 06, 2018
Dr Robert Dubois Discusses Addressing Healthcare Spending
February 14, 2018
Sara Rosenbaum on Medicaid Work Requirement and the Kentucky Lawsuit
February 15, 2018
Gail Wilensky Discusses the Impact of Waivers on State Medicaid Programs
February 19, 2018
Anne L. Schwartz Explains Data on Newly-Eligible Medicaid Enrollees
February 23, 2018
Dr Robert Dubois Discusses Tradeoffs When Allocating Healthcare Resources
February 26, 2018
Dr Robert Dubois Explains Challenges in Addressing Low-Value Services
March 09, 2018
Sara Rosenbaum Outlines Concerns Over Waivers in Medicaid Programs
March 13, 2018
Dr Anne L. Schwartz on Data in Healthcare Policy
March 15, 2018
Dr Robert Dubois on How NPC's Going Below the Surface Initiative Will Address How Well We Spend on Healthcare
March 20, 2018
Dr Anne L. Schwartz on Medicaid's Role in Addressing the Opioid Epidemic and Social Determinants of Health
March 25, 2018
Currently Reading
Sara Rosenbaum Discusses Children's Healthcare
April 01, 2018
Dr David Blumenthal Discusses the Best Practices for Getting to Value-Based Care
April 10, 2018
Sara Rosenbaum Discusses the Current Political Climate and the Effect on Medicaid
April 21, 2018
Dr David Blumenthal Outlines the Result of Mergers and Acquisitions in Healthcare
April 24, 2018
Sara Rosenbaum: A Disparities Agenda in Health Policy Is Needed
April 30, 2018
Dr David Blumenthal Looks Back as The Commonwealth Fund Celebrates 100 Years
May 06, 2018

Sara Rosenbaum Discusses Children's Healthcare

Children's healthcare is more than just the Children's Health Insurance Program (CHIP). The area of children's health policy is one that is largely misunderstood, said Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University.


What is being left out of or not being discussed in any policy debates about children’s healthcare in the US?

The question of sort of how do we think about children’s healthcare, children’s health policy, is one of those issues that has been, I would say, misunderstood for all the years that I have been working on children’s health policy, which is a long time now. We tend to boil it down to CHIP and CHIP, of course, is extremely important and Congress fortunately extended the funding for CHIP back at the very beginning of February now, end of January. And that stabilizes coverage for about 9 million children.

Of course, there are about another 36 million children or so in that part of public insurance that we know as Medicaid and some of the CHIP children are Medicaid children. So, the bigger discussion we are not having is one that takes a step back and looks at the panoramic situation of children and health insurance in the United States today and what you see is that of course we are in a very long, slow, but steady decline in terms of children’s access to their parents plans and this very long shift that began as the decline became apparent towards children in public insurance.

So, the discussion needs to be more than just are we going to fund CHIP, the little slice of public financing, but what can we do to make public insurance for children stronger? How do we make sure children remain stably covered? How do we make sure they get the scope of coverage they need and how do we use financing to generate a movement toward healthcare systems that can interact particularly well with schools, child welfare, and other services that children use?

What lessons do you think we learned form the recent battle over reauthorizing funding for CHIP?

Well, I would say lesson #1 is the next time somebody tries to sell you a Medicaid block grant, think twice. All of the block grant legislation, just like CHIP, tend to be time-regulated blocks that have to be extended and in the CHIP battle which after all was a teeny, tiny program in terms of the overall funding think about what would happen to states if suddenly the ending of a $3 trillion program was reached. What would you do at that point? I would say that the big takeaway lesson is that when the federal government tries to restate its partnership in indogen health care as we will give you some money and get out of your way, don’t believe it.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up